On Tuesday, Koninklijke Philips N.V. (NYSE:PHG) issued a correction related to the Software Version used in Trilogy Evo, Trilogy EV300, Trilogy Evo O2, and Trilogy Evo Universal ventilators to resolve ...
The U.S. Food and Drug Administration (FDA) has ordered a software recall for a type of ventilator, for fear of "serious injuries or death." The ventilators—the Philips Respironics, Inc. Trilogy EVO, ...
The FDA is getting the word out on a mandatory software update from Philips for its Trilogy line of portable life support ventilators, used in both hospitals and the home. Philips’ Respironics ...
FDA today identified Philips Respironics Trilogy Evo continuous ventilator recall as Class I, over a month after the company initiated the voluntary correction in March. The ventilators affected by ...
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Philips is updating use instructions for multiple ...
MURRYSVILLE, Pa., July 17, 2012 /PRNewswire/ --Respironics, Inc. announced today that it is voluntarily recalling 80 Trilogy Model 100 and five Trilogy Model 202 ventilators in the United States. The ...
As of last month, according to its second-quarter earnings report, Philips has produced around 99% of the repair kits and replacement devices needed to remediate its massive respiratory device recall, ...
MURRYSVILLE, Pa., Feb. 19, 2014 /PRNewswire/ -- Respironics, Inc., a Philips Healthcare business, today announced a worldwide recall of approximately 600 Philips Respironics Trilogy Ventilators, ...
(RTTNews) - Philips Respironics, affiliated to Dutch consumer electronics giant, announced additional usage instructions for Trilogy Evo Ventilators related to use of in-line nebulizers. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback